"Alleged supply of substandard paediatric medicines by your company led to the death of 66 children and has brought bad reputation to the Indian pharma industry and also likely to have an impact on the trust of international agencies on Indian pharma exports," Pharmexil, a body under the commerce and industry ministry, said to the company in a letter dated October 6.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/sv1uF4y
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Pharmexcil warns Maiden Pharmaceuticals of export certificate suspension
0 comments:
Post a Comment